These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20221967)

  • 1. [Ajmaline test].
    Said SM; Husser D; Bollmann A; Piorkowski C; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2010 Mar; 135(11):513-5. PubMed ID: 20221967
    [No Abstract]   [Full Text] [Related]  

  • 2. Ajmaline challenge in Brugada syndrome.
    Mandelburger D; Teubl A; Röggla G
    Resuscitation; 2007 Aug; 74(2):393-4. PubMed ID: 17521798
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome.
    Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER
    Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ajmaline challenge and a strange ECG.
    Martini B
    Europace; 2009 Oct; 11(10):1406; author reply 1406-7. PubMed ID: 19797154
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ajmaline challenge in young individuals with suspected Brugada syndrome.
    Sorgente A; Sarkozy A; De Asmundis C; Chierchia GB; Capulzini L; Paparella G; Henkens S; Brugada P
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):736-41. PubMed ID: 21303388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative flecainide test in Brugada syndrome patients with previous positive response.
    Abello M; Merino JL; Peinado R; Gnoatto M
    Europace; 2006 Oct; 8(10):899-900. PubMed ID: 16887868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ajmaline challenge: to stop or not to stop..
    Probst V; Le Marec H
    Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
    Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
    J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recording of high V1-V3 precordial leads may be essential to the diagnosis of Brugada syndrome during the ajmaline test.
    Teijeiro R; Garro HA; Acunzo RS; Albino E; Chiale PA
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):153-5. PubMed ID: 16891294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized and dynamic repolarization alternans in Ajmaline accentuated Brugada syndrome.
    Raviña T; Raviña M; Lapuerta JA
    Int J Cardiol; 2006 Jan; 106(1):119-22. PubMed ID: 16321676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
    Scherr D; Brunner G; Kaufmann P; Lercher P; Lueger A; Rotman B; Smolle KH; Stark G; Klein W; Krejs GJ
    Intensive Care Med; 2002 Jun; 28(6):789-92. PubMed ID: 12107687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ajmaline challenge for the diagnosis of Brugada syndrome: which protocol?
    Arnalsteen-Dassonvalle E; Hermida JS; Kubala M; Six I; Quenum S; Leborgne L; Jarry G
    Arch Cardiovasc Dis; 2010; 103(11-12):570-8. PubMed ID: 21147441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On Brugada syndrome.
    Zeller L; Shalev A
    Isr Med Assoc J; 2008 Oct; 10(10):743; author reply 743. PubMed ID: 19009962
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained ventricular tachycardia and coved-type electrocardiogram in peripheral leads: a particularly malignant phenotype of Brugada syndrome?
    Carinci V; Barbato G; Di Pasquale G
    Europace; 2014 Oct; 16(10):1507. PubMed ID: 25125570
    [No Abstract]   [Full Text] [Related]  

  • 18. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing.
    Sacher F; Jesel L; Jais P; Haïssaguerre M
    Heart Rhythm; 2014 Apr; 11(4):732-4. PubMed ID: 23732228
    [No Abstract]   [Full Text] [Related]  

  • 19. The validity of the recommended criteria for termination of the ajmaline test in diagnosing Brugada syndrome.
    Meregalli PG; Veltmann C
    Heart Rhythm; 2009 Aug; 6(8):e1; author reply e1-2. PubMed ID: 19632622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recurrent ventricular fibrillation during a febrile illness as the first manifestation of Brugada syndrome--a case report].
    Dzielińska Z; Bilińska ZT; Szumowski L; Grzybowski J; Michalak E; Przybylski A; Lubiszewska B; Walczak F; Ruzyłło W
    Kardiol Pol; 2004 Sep; 61(9):269-73. PubMed ID: 15531939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.